AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA
Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies. The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, whi...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
LIMA
Liquid biopsies and Imaging for improved cancer care
6M€
Cerrado
CANCER-ID
Cancer treatment and monitoring through identification of ci...
21M€
Cerrado
CANCER-ID
Cancer treatment and monitoring through identification of ci...
21M€
Cerrado
PLEC2021-007892
Plataforma (Oncodeeplasm) para inmunoensayos optoplasmónicos...
336K€
Cerrado
DeteCTCs
The first multi cancer liquid biopsy test for detection of e...
3M€
Cerrado
IMPED
INTEGRATED MICROFLUIDIC PLATFORM FOR PROTEOMIC AND GENETIC E...
225K€
Cerrado
Información proyecto FG_WIT
Duración del proyecto: 6 meses
Fecha Inicio: 2023-06-01
Fecha Fin: 2023-12-31
Líder del proyecto
FLOATING GENES
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
75K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies. The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, which is mostly detected in stage 4 and show 4.3 month of median survival. Floating Genes has developed and patented molecular biology tools to detect very rare circulating tumor DNA (ctDNA) in the blood. This will eventually allow earlier cancer diagnosis, precise monitoring and personalized treatment of patients with cancer. 200,000 lives could be saved every year in Europe with such an earlier diagnosis tool.